Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Sehrish Siddiqui

Member

Memphis
(901) 543-5979 TEL
(877) 521-2816 FAX

Sehrish Siddiqui

Member

Memphis
(901) 543-5979 TEL
(877) 521-2816 FAX
Memphis
(901) 543-5979 TEL
(877) 521-2816 FAX

Sehrish Siddiqui counsels a wide variety of public companies primarily in the areas of corporate finance, compliance and governance. She has served as counsel to underwriters, agents and issuers for more than 100 initial public offerings, follow-on offerings and at-the-market programs of various NYSE- and Nasdaq-traded entities. Her national and international clients include healthcare companies, real estate investment trusts, business development companies, retail and consumer product companies and investment banks.

Sehrish's practice includes:

  • Public offerings of securities for both issuers and underwriters.
  • Compliance with the registration and governance requirements of the Securities Act, Exchange Act and 1940 Act.
  • Broker-dealer compliance with applicable regulations of the Financial Industry Regulatory Authority (FINRA).
  • Other corporate matters including mergers and acquisitions and private placements.

Prior to joining the firm, Sehrish interned at the SEC in the Office of the Inspector General where she assisted with internal audits and investigations.

Memberships

American Bar Association — Young Lawyers Division; Former Sub-Grants Judge

Tennessee Bar Association — Young Lawyers Division

Memphis Bar Association

Metropolitan Inter-Faith Association — Board Member

Bass, Berry & Sims — Pro Bono Committee (2015-Present)

Bass, Berry & Sims — Professional Development Committee (2011-2013); Entry-Level Hiring Committee (2014-2015)

New Memphis Institute — Fellow (September 2014)

Leadership Germantown — Graduate (May 2015)
 

News

View More

Representative Experience

View More

Publications

View More

Accolades

Mid-South Super Lawyers "Rising Star" (2013-2017)

Marquis Who's Who — Albert Nelson Marquis Lifetime Achievement Award (2018)

Lawyers of Color "National Hotlist" (2014)

Mortar Board

University of Memphis — Outstanding Senior of the Year

Phi Kappa Phi

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.